User profiles for "author:F Corea"

Francesco Corea

Medico Neurologo Ospedaliero, SSN, Regione Umbria AUSL Umbria 2
Verified email at uslumbria2.it
Cited by 6643

Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis

…, F Caleri, F Rinaldi, F Vitetta, F Corea… - Annals of …, 2021 - Wiley Online Library
Objective This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in …

Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study

M Paciaroni, G Agnelli, F Corea, W Ageno, A Alberti… - Stroke, 2008 - Am Heart Assoc
Background and Purpose—Early hemorrhagic transformation (HT) is a complication of
ischemic stroke but its effect on patient outcome is unclear. The aims of this study were to …

Dysphagia following stroke

M Paciaroni, G Mazzotta, F Corea, V Caso… - European …, 2004 - karger.com
Background: Dysphagia is common after stroke. We aimed to study the prognosis of
dysphagia (assessed clinically) over the first 3 months after acute stroke and to determine …

Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study

…, G Tsivgoulis, K Vadikolias, C Liantinioti, F Corea… - Stroke, 2015 - Am Heart Assoc
Background and Purpose—The best time for administering anticoagulation therapy in acute
cardioembolic stroke remains unclear. This prospective cohort study of patients with acute …

DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France

…, S Cordera, C Cordioli, F Corea… - Annals of clinical …, 2021 - Wiley Online Library
We evaluated the effect of DMTs on Covid‐19 severity in patients with MS, with a pooled‐
analysis of two large cohorts from Italy and France. The association of baseline …

[HTML][HTML] Intention to receive the COVID-19 vaccine booster dose in a university community in Italy

L Folcarelli, G Miraglia del Giudice, F Corea… - Vaccines, 2022 - mdpi.com
This cross-sectional study, conducted in Naples (Italy) between 16 November and 6
December 2021, explored the willingness to receive the booster dose of the COVID-19 …

Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOAC s) …

…, A Chiti, E Giorli, G Gialdini, F Corea… - Journal of the …, 2017 - Am Heart Assoc
Background The optimal timing to administer non–vitamin K oral anticoagulants (NOAC s) in
patients with acute ischemic stroke and atrial fibrillation is unclear. This prospective …

Stroke care in Italy: an overview of strategies to manage acute stroke in COVID-19 time

…, FR Pezzella, M Paciaroni, F Corea… - European Stroke …, 2020 - journals.sagepub.com
Purpose To analyse structural and non-structural modifications of acute stroke care
pathways undertaken at healthcare institutions across the regions of Italy due to the …

[HTML][HTML] Evaluating COVID-19 vaccine willingness and hesitancy among parents of children aged 5–11 years with chronic conditions in Italy

G Miraglia del Giudice, A Napoli, F Corea, L Folcarelli… - Vaccines, 2022 - mdpi.com
COVID-19 vaccination has been extended to include children aged 5–11 years. This cross-
sectional survey evaluated parental COVID-19 vaccine willingness and hesitancy, and …

Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study

…, G Galletti, P Invernizzi, ML DeLodovici, F Corea… - Stroke, 2012 - Am Heart Assoc
Background and Purpose—The beneficial effect of intravenous thrombolytic therapy in
patients with acute ischemic stroke attributable to internal carotid artery (ICA) occlusion …